Evidence map›Paper›PMID 35885734›Full record

ReviewHealthcare (Basel, Switzerland)2022

A Systematic Review of Clinical Outcomes from Pharmacist Provided Medication Therapy Management (MTM) among Patients with Diabetes, Hypertension, or Dyslipidemia.

Srujitha Marupuru, Alexis Roether, A J Guimond, Chris Stanley, Tyler Pesqueira, David R Axon

Open access · goldAbstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Healthcare (Basel, Switzerland), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed, 1 pooled it
4.1field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 1 synthesis or guideline pooled it, 32 citations in OpenAlex.

  1. Pooled it
  2. Results of a multicenter cluster-randomized controlled clinical trial testing the effectiveness of a bioinformatics-enabled pharmacist intervention in transplant recipients.American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons · 2023
    Trial
  3. Review
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Srujitha MarupuruR. Ken Coit College of Pharmacy, The University of Arizona, Tucson, AZ 85721, USA.ORCID 0000-0003-3786-2846
Alexis RoetherR. Ken Coit College of Pharmacy, The University of Arizona, Tucson, AZ 85721, USA.
A J GuimondR. Ken Coit College of Pharmacy, The University of Arizona, Tucson, AZ 85721, USA.
Chris StanleyR. Ken Coit College of Pharmacy, The University of Arizona, Tucson, AZ 85721, USA.ORCID 0000-0001-7654-0810
Tyler PesqueiraR. Ken Coit College of Pharmacy, The University of Arizona, Tucson, AZ 85721, USA.
David R AxonR. Ken Coit College of Pharmacy, The University of Arizona, Tucson, AZ 85721, USA.ORCID 0000-0002-9903-5996
University of Arizona · US

Funding

Tabula Rasa Health Care N/A
6 · The paper itself

Abstract

This study aimed to compare the clinical outcomes of pharmacist-provided medication therapy management (MTM) services as compared to no MTM services (i.e., standard of care) on outpatient clinical outcomes for patients with diabetes, hypertension, or dyslipidemia. A systematic literature review of PubMed, EMBASE, Cochrane library, International Pharmaceutical Abstracts, PsycINFO, Scopus, CINAHL electronic databases, grey literature, websites, and journals, was conducted from 1 January 2005-20 July 2021. The search field contained a combination of keywords and MeSH terms such as: "medication therapy management", "pharmacist", "treatment outcomes". Studies published in United States, included adults ≥18 years old who received at least one pharmacist-provided MTM consultation and at least one group who received no MTM, and reported pre-specified clinical outcomes for diabetes mellitus, hypertension, or dyslipidemia were included. Of 849 studies identified, eight were included (cohort studies = 6, randomized controlled trials = 2). Clinical outcomes improved with MTM interventions, as evidenced by statistically significant changes in at least one of the three chronic conditions in most studies. Improvements were observed for diabetes outcomes (

Indexed as

clinical outcomesMedication therapy managementpharmacist

Identifiers

PMID35885734
PMCPMC9318817
OpenAlexW4283702789

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.